Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D03VYZ
|
||||
Former ID |
DIB000248
|
||||
Drug Name |
MRX-4
|
||||
Synonyms |
Non-steroidal multifunctional anti-inflammatory drug (MFAID) (nasal spray, allergic rhinitis), Morria
|
||||
Indication | Allergic rhinitis [ICD9: 472.0, 477, 995.3; ICD10:J00, J30, J31.0, T78.4] | Phase 2 | [548571] | ||
Company |
Morria Biopharmaceuticals plc
|
||||
Structure |
Download2D MOL |
||||
Target and Pathway | |||||
Target(s) | Phospholipase A2 | Target Info | Inhibitor | [551190] | |
BioCyc Pathway | Phospholipases | ||||
Pathway Interaction Database | Fc-epsilon receptor I signaling in mast cells | ||||
WikiPathways | Glycerophospholipid biosynthesis | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.